CytomX Therapeutics Inc (CTMX.OQ)
20 Apr 2018
Wed, Mar 7 2018
* CYTOMX THERAPEUTICS ANNOUNCES FULL-YEAR 2017 FINANCIAL RESULTS AND PROVIDES OPERATIONAL UPDATE
* PERCEPTIVE ADVISORS LLC REPORTS 5.6 PERCENT PASSIVE STAKE IN CYTOMX THERAPEUTICS INC AS ON DEC 8 - SEC FILING Source text (http://bit.ly/2BGceJ2) Further company coverage:
* CYTOMX THERAPEUTICS ANNOUNCES FDA ACCEPTANCE OF INVESTIGATIONAL NEW DRUG APPLICATION FOR CTLA-4 PROBODY THERAPEUTIC
* CytomX announces third quarter 2017 financial results and operational progress
* CytomX Therapeutics Inc appoints Charles S. Fuchs, M.D., MPH to board of directors Source text for Eikon: Further company coverage:
- By The Numbers: Best Biotech Stocks
- CytomX Therapeutics' (CTMX) CEO Sean McCarthy on Q4 2017 Results - Earnings Call Transcript
- ROTY Volume 1 Edition 83: Thank You For Your Patience - Launch Day Has Arrived!
- ROTY Edition 1 Volume 82: Launch Preview And Adding To A Position
- ROTY Edition 1 Volume 81: We Have A Launch Date!
- ROTY Edition 1 Volume 80: Adding To Select Positions And Continuing To Manage Risk